Company Filing History:
Years Active: 2010-2014
Title: Innovations of Marcos Timón-Jiménez
Introduction
Marcos Timón-Jiménez is a notable inventor based in San Lorenzo de El Escorial, Spain. He has made significant contributions to the field of immunization through his innovative inventions. With a total of 2 patents, his work focuses on developing effective vaccines against infectious diseases.
Latest Patents
One of his latest patents involves the use of a combination of DNA-expression constructs for producing a drug aimed at immunization against infections. This invention specifically utilizes the immunogene P36 LACK in conjunction with a thiol-specific antioxidant protein gene (TSA), kinetoplastid membrane protein 11 (KMP-11), and the GP63 antigen to elicit an immune response. The DNA-expression construct can be implemented in the form of minimalist immunologically defined gene-expression constructs (MIDGE), allowing for the production of a vaccine to treat infectious diseases. Another patent focuses on the use of DNA expression constructs for creating a remedy for immunization against leishmaniasis infections, along with a corresponding vaccine.
Career Highlights
Marcos Timón-Jiménez is currently associated with Mologen AG, where he continues to advance his research and development efforts in the field of immunology. His work has been instrumental in addressing significant health challenges through innovative solutions.
Collaborations
He collaborates with esteemed colleagues such as Burghardt Wittig and Laura Fuertes-López, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Marcos Timón-Jiménez exemplifies the spirit of innovation in the field of immunization, with his patents paving the way for new treatments against infectious diseases. His contributions are vital in the ongoing battle against health challenges worldwide.